Abstract:Background: With the growing momentum for the adoption of machine learning (ML) in medical field, it is likely that reliance on ML for imaging will become routine over the next few years. We have developed a software named BAAD, which uses ML algorithms for the diagnosis of Alzheimer's disease (AD) and prediction of mild cognitive impairment (MCI) progression. Methods: We constructed an algorithm by combining a support vector machine (SVM) to classify and a voxel-based morphometry (VBM) to reduce concerned variables. We grouped progressive MCI and AD as an AD spectrum and trained SVM according to this classification. We randomly selected half from the total 1,314 subjects of AD neuroimaging Initiative (ADNI) from North America for SVM training, and the remaining half were used for validation to fine-tune the model hyperparameters. We created two types of SVMs, one based solely on the brain structure (SVMst), and the other based on both the brain structure and Mini-Mental State Examination score (SVMcog). We compared the model performance with two expert neuroradiologists, and further evaluated it in test datasets involving 519, 592, 69, and 128 subjects from the Australian Imaging, Biomarker & Lifestyle Flagship Study of Aging (AIBL), Japanese ADNI, the Minimal Interval Resonance Imaging in AD (MIDIAD) and the Open Access Series of Imaging Studies (OASIS), respectively. Results: BAAD's SVMs outperformed radiologists for AD diagnosis in a structural magnetic resonance imaging review. The accuracy of the two radiologists was 57.5 and 70.0%, respectively, whereas, that of the SVMst was 90.5%. The diagnostic accuracy of the SVMst and SVMcog in the test datasets ranged from 88.0 to 97.1% and 92.5 to 100%, respectively. The prediction accuracy for MCI progression was 83.0% in SVMst and 85.0% in SVMcog. In the AD spectrum classified by SVMst, 87.1% of the subjects were Aβ positive according to an AV-45 positron emission tomography. Similarly, among MCI patients classified for the AD spectrum, 89.5% of the subjects progressed to AD. Conclusion: Our ML has shown high performance in AD diagnosis and prediction of MCI progression. It outperformed expert radiologists, and is expected to provide support in clinical practice.

Improving Mri-Based Diagnosis Of Alzheimer'S Disease Via An Ensemble Privileged Information Learning Algorithm

Improving Single-Modal Neuroimaging Based Diagnosis of Brain Disorders via Boosted Privileged Information Learning Framework

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Machine Learning for Diagnosis of AD and Prediction of MCI Progression From Brain MRI Using Brain Anatomical Analysis Using Diffeomorphic Deformation

Tensor-Based Multi-Modality Feature Selection and Regression for Alzheimer's Disease Diagnosis

Boosting Alzheimer Diagnosis Accuracy with the Help of Incomplete Privileged Information

Multi-Modal Data Analysis for Alzheimer’s Disease Diagnosis: An Ensemble Model Using Imagery and Genetic Features

Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis

Multi-modal Self-paced Locality Preserving Learning for Diagnosis of Alzheimer’s Disease

Ensemble learning using traditional machine learning and deep neural network for diagnosis of Alzheimer's disease

Region-of-Interest Based Sparse Feature Learning Method for Alzheimer's Disease Identification

Multimodal magnetic resonance imaging for Alzheimer's disease diagnosis using hybrid features extraction and ensemble support vector machines

Learning Deep Convolutional Features for MRI Based Alzheimer's Disease Classification

A Transfer Learning Approach for Early Diagnosis of Alzheimer’s Disease on MRI Images

A Hybrid Sequential Feature Selection Approach for the Diagnosis of Alzheimer's Disease

Ensemble learning using traditional machine learning and deep neural network for diagnosis of Alzheimer’s disease

Diagnosis of Alzheimer's disease via optimized lightweight convolution-attention and structural MRI

Nonlinearity-aware Based Dimensionality Reduction and Over-Sampling for AD/MCI Classification from MRI Measures.

Machine learning in neurological disorders: A multivariate LSTM and AdaBoost approach to Alzheimer's disease time series analysis

Multi-modality sparse representation-based classification for Alzheimer's disease and mild cognitive impairment

Ensemble deep learning approach for early diagnosis of Alzheimer's disease